临床医药实践
臨床醫藥實踐
림상의약실천
PROCEEDING OF CLINICAL MEDICINE
2015年
6期
450-453
,共4页
杜玲%贾英伟%周静%郭锦丽%段王平
杜玲%賈英偉%週靜%郭錦麗%段王平
두령%가영위%주정%곽금려%단왕평
玻璃酸钠%早期膝关节骨性关节炎%临床疗效观察
玻璃痠鈉%早期膝關節骨性關節炎%臨床療效觀察
파리산납%조기슬관절골성관절염%림상료효관찰
sodium hyaluronate%early knee osteoarthritis%clinical curative effect observation
目的:研究玻璃酸钠联合复方倍他米松关节腔内注射治疗早期膝关节骨性关节炎的短期临床疗效。方法:选择膝关节骨性关节炎患者175例,根据治疗方法不同随机分为对照组(玻璃酸钠组)和实验组(玻璃酸钠联合复方倍他米松组),对比两者的临床疗效。结果:与治疗前相比,治疗后两组在疼痛和膝关节功能方面均得到了明显改善(P<0.01),且治疗后实验组的Lysholm评分高于对照组(P<0.01),视觉模拟评分法(VAS)评分低于对照组(P<0.01)。结论:玻璃酸钠联合复方倍他米松关节腔内注射对治疗早期膝关节骨性关节炎具有良好的协同作用,临床效果较好。
目的:研究玻璃痠鈉聯閤複方倍他米鬆關節腔內註射治療早期膝關節骨性關節炎的短期臨床療效。方法:選擇膝關節骨性關節炎患者175例,根據治療方法不同隨機分為對照組(玻璃痠鈉組)和實驗組(玻璃痠鈉聯閤複方倍他米鬆組),對比兩者的臨床療效。結果:與治療前相比,治療後兩組在疼痛和膝關節功能方麵均得到瞭明顯改善(P<0.01),且治療後實驗組的Lysholm評分高于對照組(P<0.01),視覺模擬評分法(VAS)評分低于對照組(P<0.01)。結論:玻璃痠鈉聯閤複方倍他米鬆關節腔內註射對治療早期膝關節骨性關節炎具有良好的協同作用,臨床效果較好。
목적:연구파리산납연합복방배타미송관절강내주사치료조기슬관절골성관절염적단기림상료효。방법:선택슬관절골성관절염환자175례,근거치료방법불동수궤분위대조조(파리산납조)화실험조(파리산납연합복방배타미송조),대비량자적림상료효。결과:여치료전상비,치료후량조재동통화슬관절공능방면균득도료명현개선(P<0.01),차치료후실험조적Lysholm평분고우대조조(P<0.01),시각모의평분법(VAS)평분저우대조조(P<0.01)。결론:파리산납연합복방배타미송관절강내주사대치료조기슬관절골성관절염구유량호적협동작용,림상효과교호。
Objective:To study the short-term clinical curative effect on sodium hyaluronate combined with compound recipe diprospan intraarticular injection for early knee osteoarthritis. Methods:All 175 early knee osteoarthritis patients were randomly divided into two groups:the research group treated with sodium hyaluronate combined with diprospan and the control group treated with sodium hyaluronate. The short-term clinical curative effect of the two groups were comparatively analyzed. Results:After treatment,the function of pain and knee were improved. Lysholm knee functional score in research group was higher than control group( P < 0 . 0 1 ). VAS pain score of the research group was lower compared with the control group( P <0. 01). Conclusion:Sodium hyaluronate combined with diprospan has good clinical curative effect of short-term on early knee osteoarthritis.